As a result , the FDA required an additional safety clinical trial after the drug was approved and on the market to better understand these differences , and that trial was finished recently .
These problems included heart attacks , strokes , and heart - related deaths .
The FDA required an additional safety clinical trial after the drug was approved and on the market to better understand these differences , and that trial was finished recently .
These problems included heart attacks , strokes , and heart - related deaths .